Logo | Name | Σ | ||
---|---|---|---|---|
MSD At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse … Sectors: Pharmaceutical | 2104 | 1853 | 189 | |
Sanofi We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare Tags: CAC40 Sectors: Pharmaceutical | 3457 | 2577 | 830 | |
CogX Festival CogX's mission is to convene the tech industry, global leaders, changemakers, creatives and policy makers together to address the critical question 'How do we get the next 10 years right?'. We do this through our Festivals and Summits, combining leading speakers, highly focused content sessions and executive networking. Often described as a ‘festival of ideas’ with the heart of a meet up and the polish of Davos, CogX is an opportunity to immerse yourself in all things AI. We are thrilled to be hosting two events in 2024, The Leadership Summit in London on October 7th, and even sooner … | 1038 | 338 | 668 |